Format

Send to

Choose Destination
J Clin Endocrinol Metab. 2012 Apr;97(4):1146-52. doi: 10.1210/jc.2011-2218. Epub 2012 Mar 22.

IOM committee members respond to Endocrine Society vitamin D guideline.

Author information

1
Maine Medical Center Research Institute, 81 Research Drive, Scarborough, Maine 04074, USA. crofen@gmail.com

Abstract

In early 2011, a committee convened by the Institute of Medicine issued a report on the Dietary Reference Intakes for calcium and vitamin D. The Endocrine Society Task Force in July 2011 published a guideline for the evaluation, treatment, and prevention of vitamin D deficiency. Although these reports are intended for different purposes, the disagreements concerning the nature of the available data and the resulting conclusions have caused confusion for clinicians, researchers, and the public. In this commentary, members of the Institute of Medicine committee respond to aspects of The Endocrine Society guideline that are not well supported and in need of reconsideration. These concerns focus on target serum 25-hydroxyvitamin D levels, the definition of vitamin D deficiency, and the question of who constitutes a population at risk vs. the general population.

PMID:
22442278
PMCID:
PMC5393439
DOI:
10.1210/jc.2011-2218
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center